Abstract: The 2017 Annual Meeting of the American Society of Clinical Oncology (ASCO) was held on June 2-6, 2017 in Chicago, United States. And the academic event showed the frontier researches in the field of oncology. Survival prediction in patients treated by FOLFIRI regimen and bevacizumab for metastatic colorectal cancer using radiomics approach was made in Abstract 3601. Authors aim to summarize the application and development of radiomics in digestive system tumors.